SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-17-008638
Filing Date
2017-02-14
Accepted
2017-02-14 14:40:02
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHANDELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VIII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A v459516_sc13da.htm SC 13D/A 122959
  Complete submission text file 0001144204-17-008638.txt   124662
Mailing Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402
Business Address 160 BOVET RD, SUITE 408 SAN MATEO CA 94402 650-854-9650
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87705 | Film No.: 17607282
SIC: 2834 Pharmaceutical Preparations